Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M47.2Revenue (TTM) $M69.6Net Margin (%)70.9Altman Z-Score-3.6
Enterprise Value $M19.1EPS (TTM) $0.6Operating Margin %47.2Piotroski F-Score5
P/E(ttm)1.1Beneish M-Score9.3Pre-tax Margin (%)70.9Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio7.9Cash flow > EarningsN
Price/Sales0.75-y EBITDA Growth Rate %--Current Ratio7.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)110Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)261Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with THLD

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

THLD is held by these investors:



THLD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fernandes Joel ASenior Vice President 2015-09-28Buy3,562$3.96-83.33view
JAEGER WILFRED EDirector 2015-02-18Buy25,000$3.75-82.4view
Davar NipunVice President 2014-10-13Buy3,000$2.99-77.93view
YOUNGER WILLIAM H JR10% Owner 2014-10-01Sell242,396$3.77-82.49view
WHITE JAMES N10% Owner 2014-10-01Sell239,538$3.77-82.49view
SWEET DAVID E10% Owner 2014-10-01Sell229,154$3.77-82.49view
Speiser Michael L10% Owner 2014-10-01Sell227,228$3.77-82.49view
SHEEHAN ANDREW T10% Owner 2014-10-01Sell230,352$3.77-82.49view
Pullara Samuel J III10% Owner 2014-10-01Sell226,657$3.77-82.49view
GAITHER JAMES C10% Owner 2014-10-01Sell231,287$3.77-82.49view

Press Releases about THLD :

Quarterly/Annual Reports about THLD:

News about THLD:

Articles On GuruFocus.com
Tuesday Pre-Market Insights: THLD, PLL, AOL, CALL May 12 2015 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 47,619 Shares Mar 15 2011 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 52,356 Shares Oct 06 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 20,000 Shares Jun 05 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold... Jan 26 2017
Hurry! These 5 Stocks Are About to Break Out Explosively Jan 13 2017
Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424 Dec 19 2016
Is Threshold Pharmaceuticals, Inc. (THLD) A Good Stock To Buy? Dec 12 2016
THRESHOLD PHARMACEUTICALS INC Financials Nov 15 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Nov 15 2016
Merck KGaA expects profit gain from lower development costs Nov 15 2016
Threshold Pharmaceuticals Reports Third Quarter Financial Results Nov 07 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 07 2016
Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting... Oct 25 2016
Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting... Oct 25 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 18 2016
Is Threshold Pharmaceuticals a Buy? (THLD) Oct 03 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change... Sep 30 2016
Why Investors Are Buzzing About Threshold Pharmaceuticals, Enbridge, Facebook and More Sep 30 2016
COO of Threshold Pharmaceuticals to Resign (THLD) Sep 29 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus... Sep 29 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Sep 29 2016
Key FDA Decisions and Trial Results Coming in the Next 2 Months Sep 14 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events Sep 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)